Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vulnerable atherosclerotic plaque: clinical implications.

Jinho Shin1, Jay E Edelberg, Mun K Hong

  • 1Department of Internal Medicine (Division of Cardiology), New York Presbyterian Hospital--Weill Cornell Campus, New York, USA.

Current Vascular Pharmacology
|August 24, 2004
PubMed
Summary

Predicting and preventing acute coronary syndrome (ACS), a major cause of death from coronary artery disease (CAD), is crucial. Understanding vulnerable plaque rupture, driven by inflammation, offers new avenues for intervention and improved patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to Letter to the Editor: "Efficacy and Safety of Combination Therapy With Low Dose of Telmisartan and S-Amlodipine in Patients With Hypertension: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical Trial".

Clinical therapeutics·2026
Same author

Efficacy and Safety of Fimasartan/Indapamide Combination Therapy versus Fimasartan Monotherapy in Patients with Essential Hypertension Inadequately Responding to Fimasartan 30 mg (FINEDUO): A Randomized, Double-Blind, Multicenter, Phase III Study.

Drug design, development and therapy·2026
Same author

Low-Dose Telmisartan/Amlodipine in Essential Hypertension: A Phase III Trial.

Journal of clinical hypertension (Greenwich, Conn.)·2026
Same author

Asian expert consensus on high-quality hypertension management.

Hypertension research : official journal of the Japanese Society of Hypertension·2026
Same author

Gastrointestinal Stromal Tumor: History, Molecular Subtypes, and Risk Stratification.

Journal of gastric cancer·2026
Same author

Predictive Value of Insertion/Deletion Rate in Patients With Gastric Cancer Treated With Nivolumab Plus Chemotherapy.

Journal of gastric cancer·2026

Area of Science:

  • Cardiology
  • Atherosclerosis Research

Background:

  • Coronary Artery Disease (CAD) is the leading global cause of mortality and morbidity.
  • Acute Coronary Syndrome (ACS), including myocardial infarction, is a catastrophic manifestation of CAD, often unpredictable.
  • Current treatments improve CAD management, yet ACS still causes significant sudden death and disability.

Purpose of the Study:

  • To explore the prediction and prevention of ACS.
  • To investigate the role of vulnerable atherosclerotic plaques in ACS development.
  • To highlight potential therapeutic strategies targeting plaque stabilization and rupture prevention.

Main Methods:

  • Review of existing studies on CAD, ACS, and atherosclerotic plaque rupture.
  • Analysis of autopsy and clinical findings regarding plaque vulnerability.

Related Experiment Videos

  • Examination of evidence from lipid-lowering and antiplatelet therapy trials.
  • Consideration of advanced imaging modalities for plaque diagnosis.

    • Main Results:

    • The majority of ACS events originate from non-obstructive, "vulnerable" atherosclerotic lesions.
    • Plaque vulnerability is a systemic process, often involving multiple sites.
    • Inflammation plays a pivotal role in the inciting factors of vulnerable plaque rupture.
    • Lipid-lowering and antiplatelet therapies demonstrate efficacy in reducing acute coronary events, suggesting plaque stabilization benefits.
    • Imaging techniques show promise in identifying vulnerable plaques.

    Conclusions:

    • Preventing ACS requires understanding and targeting vulnerable plaque rupture.
    • Inflammation is a key factor in plaque instability.
    • Therapeutic strategies focusing on plaque stabilization and antiplatelet therapy are vital for reducing ACS incidence.
    • Future advancements in imaging may enable proactive prevention of acute coronary events.